Related Experiment Video
Updated: Jul 4, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year
Julio G Tejada1, Maite Velazquez, Felipe Hernandez
1Servicio de Cardiología, Hospital doce de Octubre, Madrid, Spain. juliogtejada@yahoo.com
Insights
Percutaneous interventions (PI) are safe and effective for patients with prior coronary artery bypass graft (CABG) surgery. Key predictors of 1-year major adverse cardiac events include left ventricular dysfunction and multivessel intervention.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery Outcomes
Background:
- Increasing number of patients with prior coronary artery bypass graft (CABG) surgery are undergoing percutaneous interventions (PI).
- The clinical outcomes of PI in post-CABG patients remain unclear.
- This study evaluates the safety and efficacy of PI in this specific patient population.
Purpose of the Study:
- To assess the immediate and 1-year clinical outcomes of percutaneous interventions (PI) in patients with a history of coronary artery bypass graft (CABG) surgery.
- To identify predictors of major adverse cardiac events (MACE) in this cohort.
Main Methods:
- A retrospective analysis of 91 post-CABG patients who underwent 197 stent implantations between January 2005 and September 2006.
- Procedures involved native coronary arteries, grafts, or both, with 84% utilizing drug-eluting stents.
- In-hospital and 1-year major adverse cardiac events (MACE) were meticulously recorded.
Main Results:
- High procedural success rate of 95.6% with a low in-hospital MACE rate of 3.3%.
- At 1-year follow-up, the MACE incidence was 18.6%, including 5.4% mortality and 2.2% myocardial infarction.
- Repeat revascularization was needed in 10.9% of patients; multivariate analysis identified left ventricular ejection fraction <50% and multivessel intervention as independent predictors of MACE.
Conclusions:
- Percutaneous revascularization demonstrates safety and efficacy in post-CABG patients.
- The study highlights a low rate of target lesion revascularization, which is encouraging.
- Left ventricular dysfunction and multivessel intervention are significant independent predictors of 1-year MACE in this population.
Background:
An increasing number of patients undergoing percutaneous interventions (PI) have experienced previous coronary artery bypass graft surgery (CABG). However, the impact of PI on outcomes in such patients is currently unclear. We evaluated the immediate and 1-year clinical outcomes of post-CABG patients who underwent PI in a tertiary center.
Methods:
From January-2005 to September-2006, 91 consecutive post-CABG patients underwent 197 stent implantations (84% drug-eluting stents) for 154 lesions. 58% were treated in the native coronary arteries, 34% in the grafts and 8% in both type of vessels. Major adverse cardiac events (MACE) were recorded in-hospital and at 1-year follow-up.
Results:
Procedural success rate was 95.6%. In-hospital MACE rate was 3.3%. At 1 year, the incidence of MACE was 18.6%: death occurred in 5.4% of the patients, myocardial infarction in 2.2%, and 10.9% of the patients underwent repeat revascularization (target lesion revascularization was required in 5.4%). Multivariate analysis revealed left ventricular ejection fraction <50% (OR 4.6, 95% CI 1.8 to 7.5, p=0.01) and multivessel intervention (OR 2.7, 95% CI 1.2 to 4.5, p=0.03) to be independent predictors of MACE at 1 year.
Conclusions:
Immediate results showed the safety and efficacy of percutaneous revascularization in post-CABG patients. The relatively low risk need for target lesion revascularization obtained is encouraging. Independent predictors of MACE at 1 year were left ventricular disfunction and multivessel intervention.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care